LiuPPBletASmythD, et al.
The science underlying COVID-19: implications for the cardiovascular system.Circulation2020; in press.
2.
BourouibaL.Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19.JAMA2020; in press.
3.
FrantzEDCProdelEBrazID, et al.
Modulation of the renin–angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training. Clin Sci (Lond)2018;
132: 1487–1507. doi: 10.1042/CS20180276.
4.
PagliaroPPennaC.Rethinking the renin–angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther2005;
19: 77–87.
5.
HoffmannMKleine-WeberHSchroederS, et al.
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell2020;
181: 271–280.e8. doi:10.1016/j.cell.2020.02.052.
6.
Motta-SantosDDos SantosRAOliveiraM, et al.
Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise. Hypertens Res2016; 39: 506–512.
7.
MuñozMCGianiJFDominiciFP.Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul Pept2010;
161: 1–7. doi: 10.1016/j.regpep.2010.02.001.
8.
HamadaTKotaniKNagaiN, et al.
Genetic polymorphisms of the renin-angiotensin system and obesity-related metabolic changes in response to low-energy diets in obese women. Nutrition2011;
27: 34–39. https://doi.org/10.1016/j.nut.2009.10.012.
9.
CrisafulliAPagliaroPRobertoS, et al.
Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning.Int J Mol Sci2020; in press.
10.
KempsHKränkelNDörrM, et al.
Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019;
26: 709–727.
11.
KränkelNBahlsMVan CraenenbroeckEM, et al.
Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: how does it work? Eur J Prev Cardiol2019;
26: 701–708.
12.
RossiGPSangaVBartonM.Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife2020;
9: pii: e57278. doi: 10.7554/eLife.57278.
